查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908737

临床试验支援服务市场规模、份额和趋势分析报告：按阶段、服务、申办者、地区和细分市场预测，2026-2033年

Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phases (Phase I, Phase II, Phase III, Phase IV), By Service, By Sponsor, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

临床试验支援服务市场概况

全球临床试验支援服务市场预计到 2025 年价值 256.2 亿美元，预计到 2033 年将达到 470 亿美元。

预计从 2026 年到 2033 年，全球检测市场将以 7.93% 的复合年增长率成长。由于新兴经济体对检测的需求不断增长、研发投资不断扩大以及受託研究机构(CRO) 的数量增加，全球市场预计将迅速扩张。

受专利到期影响，製药公司的研发投入逐年稳定成长。虽然专利通常有效期为20年，但製药业现行的製度允许学名药在10年后进入市场。这促使各公司加大研发投入以加速药物研发，进而推动了整体市场成长。

临床试验支援服务在药物研发中发挥至关重要的作用，包括试验设计和临床试验执行。这些服务还涵盖临床试验设施的升级改造、临床实验药物的购买和储存、药物剂量计算以及试剂盒处理。临床试验服务为临床前基础设施和研究提供支持，包括临床试验中心支持、临床实验药物的采购和储存、临床实验药物的盲法实施、患者招募、数据核对以及药物退回核对。

此外，新技术的日益普及正在推动市场成长。大多数资料管理软体被称为「临床资料管理 (CDM)」系统。 CDM 系统对于多中心临床试验处理大量资料至关重要。製药公司使用的 CDM 系统大多是商业软体，但也存在一些开放原始码工具。 Oracle Clinical、Clintrial、Oracle Clinical Macro、RAVE 和 eClinical Suite 都是典型的 CDM 工具。维护资料管理活动的审核追踪对于监管申报至关重要。这些 CDM 工具有助于确保审核追踪并管理差异。 CDM 活动包括资料收集、病例报告表 (CRF) 註释、CRF 追踪、资料库设计、资料输入、医学编码、资料检验、差异管理和资料库锁定。

目录

第一章调查方法和范围

第二章执行摘要

第三章 临床试验支持服务市场变数、趋势与范围

  • 市场谱系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 研发成本分析
  • 科技趋势
  • 临床试验数量分析（2024 年）
  • 定价分析
  • 关税和贸易协定的影响分析
  • 价值链分析
    • 供应趋势
    • 需求趋势
  • 市场分析工具
    • 波特五力分析
    • PESTEL 分析与 SWOT 分析

第四章：临床试验支援服务市场：按阶段分類的估算与趋势分析

  • 临床试验支援服务市场：按阶段分類的波动分析
  • 临床试验支援服务市场按阶段分類的估算与预测，2021-2033年
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第五章 临床试验支援服务市场：按服务类型分類的估算与趋势分析

  • 临床试验支援服务市场：按服务类型分類的波动分析
  • 临床试验支援服务市场按服务类型分類的估算与预测，2021-2033年
  • 临床试验中心管理
  • 病患招募管理
    • 病患招募及登记服务
    • 患者留存率
    • 其他的
  • 资料管理
  • 管理人员
  • IRB
  • 其他的

第六章：临床试验支援服务市场：依申办方分類的估算与趋势分析

  • 临床试验支援服务市场：申办方变化分析
  • 2021-2033年按申办方分類的临床试验支援服务市场估算与预测
  • 製药和生物製药公司
  • 医疗设备製造商
  • 其他的

第七章 临床试验支援服务市场：区域估算与趋势分析

  • 区域市场概览
  • 2025年及2033年区域市占率分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 卡达
    • 阿曼

第八章 竞争情势

  • 主要参与者的分类
    • Market Leaders
    • Emerging Players
  • 2025年市场估值分析（热力图分析）
  • 公司简介
    • Charles River Laboratories International, Inc.
    • Wuxi Apptec, Inc
    • Iqvia Holdings, Inc
    • Syneos Health, Inc.
    • Eurofins Scientific
    • PPD, Inc.（Pharmaceutical Product Development）
    • Icon Plc
    • Laboratory Corporation of America Holdings（Labcorp）
    • Alcura
    • Parexel International Corporation
Product Code: GVR-4-68039-475-9

Clinical Trials Support Services Market Summary

The global clinical trials support services market size was estimated at USD 25.62 billion in 2025 and is projected to reach USD 47.00 billion by 2033, growing at a CAGR of 7.93% from 2026 to 2033. The global market is projected to expand rapidly due to rising demand for trials in emerging economies, increasing R&D investment, and a growing number of contract research organizations (CROs).

The pharmaceutical firms' (R&D) venture has been steadily growing every year, mainly due to patent expirations. An ordinary patent terminates after 20 years; in the pharmaceutical area, there is an arrangement that provides for the entry of a generic version of the medication into the market following a period of 10 years. Thus, companies are increasing their R&D investments to accelerate the development of drugs, thereby expanding the entire market.

Clinical trials support services are quite useful in the event of a drug, such as assay design and clinical testing. It also covers tasks such as strengthening clinical test locations, securing and storing research medications, calculating drug dosages, and handling kits. Preclinical groundwork and research are supported by clinical test services, which include clinical test site assistance, obtaining & storing study drugs, blinding of drugs for studies, patient recruitment, coordination, and reconciliation of returned medications.

In addition, growing adoption of new technologies has fueled market growth. Many software tools for data management are referred to as "Clinical Data Management" (CDM) systems. Multicentric trials require CDM systems to handle massive volumes of data. The majority of CDM systems used by pharmaceutical companies are commercial, but a few open-source tools are also available. Oracle Clinical, Clintrial, Oracle Clinical, Macro, RAVE, and eClinical Suite are common CDM tools. Maintaining an audit record of data management actions is important in regulatory submissions. These CDM tools help ensure the audit trail and manage discrepancies. The CDM activities include data collection, CRF annotation, CRF tracking, database design, data entry, medical coding, data validation, discrepancy management, and database lock.

Global Clinical Trials Support Services Market Report Segmentation

This report forecasts revenue growth at the regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the clinical trials support services market report based on the phases, service,sponsor and region:

  • Phases Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Trial Site Management
  • Patient Recruitment Management
    • Patient recruitment & Registry Services
    • Patient retention
    • Others
  • Data Management
  • Administrative Staff
  • IRB
  • Others
  • Sponsor Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & biopharmaceutical companies
  • Medical device companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Oman
    • Qatar
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Phases
    • 1.2.2. Service
    • 1.2.3. Sponsor
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Support Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
  • 3.3. R&D Spending Analysis
  • 3.4. Technology Landscape
  • 3.5. Clinical Trial Volume Analysis, 2024
  • 3.6. Pricing Analysis
  • 3.7. Tariff and Trade Agreement Impact Analysis
  • 3.8. Value Chain Analysis
    • 3.8.1. Supply Trends
    • 3.8.2. Demand Trends
  • 3.9. Market Analysis Tools
    • 3.9.1. Porter's Five Force Analysis
    • 3.9.2. PESTEL by SWOT Analysis

Chapter 4. Clinical Trials Support Services Market: Phases Estimates & Trend Analysis

  • 4.1. Clinical Trials Support Services Market, by Phases: Segment Dashboard
  • 4.2. Clinical Trials Support Services Market, by Phases: Movement Analysis
  • 4.3. Clinical Trials Support Services Market Estimates & Forecasts, by Phases, 2021 - 2033 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical Trials Support Services Market: Service Estimates & Trend Analysis

  • 5.1. Clinical Trials Support Services Market, by Service: Segment Dashboard
  • 5.2. Clinical Trials Support Services Market, by Service: Movement Analysis
  • 5.3. Clinical Trials Support Services Market Estimates & Forecasts, by Service, 2021 - 2033 (USD Million)
  • 5.4. Clinical Trial Site Management
    • 5.4.1. Clinical Trial Site Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Patient Recruitment Management
    • 5.5.1. Patient Recruitment Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Patient Recruitment & Registry Services
      • 5.5.2.1. Patient Recruitment & Registry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Patient Retention
      • 5.5.3.1. Patient Retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Data Management
    • 5.6.1. Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Administrative Staff
    • 5.7.1. Administrative Staff Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. IRB
    • 5.8.1. IRB Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical Trials Support Services Market: Sponsor Estimates & Trend Analysis

  • 6.1. Clinical Trials Support Services Market, by Sponsor: Segment Dashboard
  • 6.2. Clinical Trials Support Services Market, by Sponsor: Movement Analysis
  • 6.3. Clinical Trials Support Services Market Estimates & Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical & Biopharmaceutical Companies
    • 6.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Medical Device Companies
    • 6.5.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Clinical Trials Support Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2025 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Australia
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. Colombia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Colombia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Qatar
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Oman
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Key Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Charles River Laboratories International, Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Wuxi Apptec, Inc
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Iqvia Holdings, Inc
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Syneos Health, Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Eurofins Scientific
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. PPD, Inc. (Pharmaceutical Product Development)
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Icon Plc
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Laboratory Corporation of America Holdings (Labcorp)
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Alcura
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Parexel International Corporation
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiative

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 4 Global Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 5 Global Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 6 North America Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 8 North America Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 9 North America Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 10 U.S. Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 11 U.S. Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 12 U.S. Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 13 Canada Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 14 Canada Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 15 Canada Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 16 Mexico Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 17 Mexico Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 Mexico Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 19 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 21 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 23 UK Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 24 UK Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 25 UK Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 26 Germany Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 27 Germany Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Germany Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 29 France Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 30 France Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 31 France Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 32 Italy Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 33 Italy Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 34 Italy Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 35 Spain Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 36 Spain Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 Spain Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 38 Denmark Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 39 Denmark Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 Denmark Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 41 Sweden Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 42 Sweden Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Sweden Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 44 Norway Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 45 Norway Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 46 Norway Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 51 China Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 52 China Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 53 China Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 54 India Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 55 India Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 56 India Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 57 Japan Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 58 Japan Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 59 Japan Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 60 Australia Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 61 Australia Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 62 Australia Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 63 South Korea Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 64 South Korea Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 South Korea Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 66 Thailand Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 67 Thailand Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 68 Thailand Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 69 Latin America Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 71 Latin America Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 72 Brazil Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 73 Brazil Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 74 Brazil Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 75 Argentina Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 76 Argentina Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 77 Argentina Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 78 Colombia Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 79 Colombia Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 80 Colombia Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 84 South Africa Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 85 South Africa Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 86 South Africa Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 90 UAE Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 91 UAE Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 92 UAE Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 96 Oman Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 97 Oman Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 98 Oman Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 99 Qatar Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 100 Qatar Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 101 Qatar Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Clinical Trials Support Services Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Clinical Trials Support Services Market: Phases outlook and key takeaways
  • Fig. 20 Clinical Trials Support Services Market: Phases movement analysis
  • Fig. 21 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Clinical Trials Support Services Market: Service outlook and key takeaways
  • Fig. 26 Clinical Trials Support Services Market: Service movement analysis
  • Fig. 27 Clinical Trial Site Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Patient Recruitment Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Patient recruitment & Registry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Patient retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Administrative Staff Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 IRB Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Clinical Trials Support Services Market: Sponsor outlook and key takeaways
  • Fig. 37 Clinical Trials Support Services Market: Sponsor movement analysis
  • Fig. 38 Clinical Trial Site Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Regional Marketplace: Key Takeaways
  • Fig. 43 North America Clinical Trials Support Services Market Estimates and Forecasts, 2018-2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Mexico Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Europe Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Germany Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 France Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Italy Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Spain Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Denmark Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Sweden Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 China Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 South Korea Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Latin America Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Brazil Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Argentina Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Colombia Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 MEA Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 UAE Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Qatar Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Oman Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key company categorization
  • Fig. 101 Service heat map analysis
  • Fig. 102 Strategic framework